Publication:
Einführung der Pathogeninaktivierung für Thrombozytenkonzentrate in der Schweiz

Simple item page
cris.virtual.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtual.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtualsource.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtualsource.author-orcid#PLACEHOLDER_PARENT_METADATA_VALUE#
cris.virtualsource.author-orcid5f5278c3-d908-45fe-8a4a-885030ed281d
dc.contributor.authorJutzi, Markus
dc.contributor.authorRüesch, Morven
dc.contributor.authorMansouri Taleghani, Behrouz
dc.date.accessioned2024-10-15T06:37:43Z
dc.date.available2024-10-15T06:37:43Z
dc.date.issued2013
dc.description.numberOfPages5
dc.description.sponsorshipUniversitätsklinik für Hämatologie und Hämatologisches Zentrallabor
dc.identifier.doi10.7892/boris.48659
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/119292
dc.language.isode
dc.publisherEMH Editores Medicorum Helveticorum
dc.relation.ispartofSchweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS
dc.relation.issn1424-3784
dc.relation.organizationDCD5A442C055E17DE0405C82790C4DE2
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleEinführung der Pathogeninaktivierung für Thrombozytenkonzentrate in der Schweiz
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage226
oaire.citation.issue11
oaire.citation.startPage222
oaire.citation.volume13
oairecerif.author.affiliation#PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation#PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliationUniversitätsklinik für Hämatologie und Hämatologisches Zentrallabor
oairecerif.author.affiliation2#PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation2#PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation2#PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation3#PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation3#PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation3#PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation4#PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation4#PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation4#PLACEHOLDER_PARENT_METADATA_VALUE#
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.description.ispublishedpub
unibe.eprints.legacyId48659
unibe.journal.abbrevTitleSchweiz Med Forum
unibe.refereedTRUE
unibe.subtype.articlereview

Files

Original bundle
Now showing 1 - 1 of 1
Name:
2013_Einführung der Pathogeninaktivierung für Thrombozytenkonzentrate in der Schweiz_B. Mansourit.pdf
Size:
340 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by-nc-nd/4.0
Content:
published
Download

Collections

Publications